188 related articles for article (PubMed ID: 2495286)
1. High levels of human apolipoprotein A-I in transgenic mice result in increased plasma levels of small high density lipoprotein (HDL) particles comparable to human HDL3.
Walsh A; Ito Y; Breslow JL
J Biol Chem; 1989 Apr; 264(11):6488-94. PubMed ID: 2495286
[TBL] [Abstract][Full Text] [Related]
2. Expression of the human apolipoprotein A-I gene in transgenic mice alters high density lipoprotein (HDL) particle size distribution and diminishes selective uptake of HDL cholesteryl esters.
Chajek-Shaul T; Hayek T; Walsh A; Breslow JL
Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6731-5. PubMed ID: 1907375
[TBL] [Abstract][Full Text] [Related]
3. Functional lecithin:cholesterol acyltransferase deficiency and high density lipoprotein deficiency in transgenic mice overexpressing human apolipoprotein A-II.
Marzal-Casacuberta A; Blanco-Vaca F; Ishida BY; Julve-Gil J; Shen J; Calvet-Márquez S; González-Sastre F; Chan L
J Biol Chem; 1996 Mar; 271(12):6720-8. PubMed ID: 8636092
[TBL] [Abstract][Full Text] [Related]
4. High density lipoprotein particle size restriction in apolipoprotein A-I(Milano) transgenic mice.
Bielicki JK; Forte TM; McCall MR; Stoltzfus LJ; Chiesa G; Sirtori CR; Franceschini G; Rubin EM
J Lipid Res; 1997 Nov; 38(11):2314-21. PubMed ID: 9392429
[TBL] [Abstract][Full Text] [Related]
5. A polymorphism affecting apolipoprotein A-II translational efficiency determines high density lipoprotein size and composition.
Doolittle MH; LeBoeuf RC; Warden CH; Bee LM; Lusis AJ
J Biol Chem; 1990 Sep; 265(27):16380-8. PubMed ID: 2118905
[TBL] [Abstract][Full Text] [Related]
6. Expression of human apolipoprotein A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-I and the appearance of two new high density lipoprotein size subclasses.
Rubin EM; Ishida BY; Clift SM; Krauss RM
Proc Natl Acad Sci U S A; 1991 Jan; 88(2):434-8. PubMed ID: 1703299
[TBL] [Abstract][Full Text] [Related]
7. Lipid transfer particle-induced transformation of human high density lipoprotein into apolipoprotein A-I-deficient low density particles.
Silver ET; Scraba DG; Ryan RO
J Biol Chem; 1990 Dec; 265(36):22487-92. PubMed ID: 2125050
[TBL] [Abstract][Full Text] [Related]
8. Distribution of apolipoprotein A-IV in human plasma.
Bisgaier CL; Sachdev OP; Megna L; Glickman RM
J Lipid Res; 1985 Jan; 26(1):11-25. PubMed ID: 3919133
[TBL] [Abstract][Full Text] [Related]
9. Expression of human apolipoprotein A-II and its effect on high density lipoproteins in transgenic mice.
Schultz JR; Gong EL; McCall MR; Nichols AV; Clift SM; Rubin EM
J Biol Chem; 1992 Oct; 267(30):21630-6. PubMed ID: 1400473
[TBL] [Abstract][Full Text] [Related]
10. Plasma lipoprotein composition in alcoholic hepatitis: accumulation of apolipoprotein E-rich high density lipoprotein and preferential reappearance of "light'-HDL during partial recovery.
Weidman SW; Ragland JB; Sabesin SM
J Lipid Res; 1982 May; 23(4):556-69. PubMed ID: 7097121
[TBL] [Abstract][Full Text] [Related]
11. A mutation in the human apolipoprotein A-I gene. Dominant effect on the level and characteristics of plasma high density lipoproteins.
Deeb SS; Cheung MC; Peng RL; Wolf AC; Stern R; Albers JJ; Knopp RH
J Biol Chem; 1991 Jul; 266(21):13654-60. PubMed ID: 1906882
[TBL] [Abstract][Full Text] [Related]
12. Impact of genetic deletion of platform apolipoproteins on the size distribution of the murine lipoproteome.
Gordon SM; Li H; Zhu X; Tso P; Reardon CA; Shah AS; Lu LJ; Davidson WS
J Proteomics; 2016 Sep; 146():184-94. PubMed ID: 27385375
[TBL] [Abstract][Full Text] [Related]
13. Changes in the distribution and composition of plasma high density lipoproteins after ingestion of fat.
Tall AR; Blum CB; Forester GP; Nelson CA
J Biol Chem; 1982 Jan; 257(1):198-207. PubMed ID: 6796585
[TBL] [Abstract][Full Text] [Related]
14. Influence of mouse apolipoprotein A-II on plasma lipoproteins in transgenic mice.
Hedrick CC; Castellani LW; Warden CH; Puppione DL; Lusis AJ
J Biol Chem; 1993 Sep; 268(27):20676-82. PubMed ID: 8376417
[TBL] [Abstract][Full Text] [Related]
15. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.
Julve J; Escolà-Gil JC; Rotllan N; Fiévet C; Vallez E; de la Torre C; Ribas V; Sloan JH; Blanco-Vaca F
Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):232-8. PubMed ID: 19910634
[TBL] [Abstract][Full Text] [Related]
16. Decreased HDL cholesterol levels but normal lipid absorption, growth, and feeding behavior in apolipoprotein A-IV knockout mice.
Weinstock PH; Bisgaier CL; Hayek T; Aalto-Setala K; Sehayek E; Wu L; Sheiffele P; Merkel M; Essenburg AD; Breslow JL
J Lipid Res; 1997 Sep; 38(9):1782-94. PubMed ID: 9323588
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein (apo) A-I production and mRNA abundance explain plasma apoA-I and high density lipoprotein differences between two nonhuman primate species with high and low susceptibilities to diet-induced hypercholesterolemia.
Sorci-Thomas M; Prack MM; Dashti N; Johnson F; Rudel LL; Williams DL
J Biol Chem; 1988 Apr; 263(11):5183-9. PubMed ID: 3128537
[TBL] [Abstract][Full Text] [Related]
18. Human secretory phospholipase A2 mediates decreased plasma levels of HDL cholesterol and apoA-I in response to inflammation in human apoA-I transgenic mice.
Tietge UJ; Maugeais C; Lund-Katz S; Grass D; deBeer FC; Rader DJ
Arterioscler Thromb Vasc Biol; 2002 Jul; 22(7):1213-8. PubMed ID: 12117740
[TBL] [Abstract][Full Text] [Related]
19. Expression of human apolipoprotein A-I/C-III/A-IV gene cluster in mice induces hyperlipidemia but reduces atherogenesis.
Vergnes L; Baroukh N; Ostos MA; Castro G; Duverger N; Nanjee MN; Najib J; Fruchart JC; Miller NE; Zakin MM; Ochoa A
Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2267-74. PubMed ID: 11031214
[TBL] [Abstract][Full Text] [Related]
20. ApoA-IHelsinki (Lys107-->0) associated with reduced HDL cholesterol and LpA-I:A-II deficiency.
Tilly-Kiesi M; Zhang Q; Ehnholm S; Kahri J; Lahdenperä S; Ehnholm C; Taskinen MR
Arterioscler Thromb Vasc Biol; 1995 Sep; 15(9):1294-306. PubMed ID: 7670941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
